Predictive values of ACUITY-PCI scores in patients with non-ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention
-
摘要: 目的:探讨ACUITY-PCI评分系统对接受经皮冠状动脉介入 (PCI) 治疗的急性非ST段抬高心肌梗死 (NSTEMI) 患者预后的预测价值。方法:收集北京安贞医院抢救中心2009-01-2012-12住院的急性NSTEMI患者进行ACUITY-PCI评分, 并对入选病例进行长期随访, 随访终点为全因性死亡、非致命性心肌梗死、再次血运重建。结果:随访2年, 统计47例患者发生的心血管不良事件, 其中低分组4例, 发生率8.5%;中分组22例, 发生率46.8%;高分组21例, 发生率44.7%。高分组、中分组与低分组比较差异有统计学意义 (log-rank P＜0.001) 。ROC曲线分析结果显示, 曲线下面积=0.727[95%CI (0.656, 0.797), P＜0.001]。结论:ACUITYPCI评分是预测接受PCI治疗的急性NSTEMI患者预后的理想工具。
-
关键词:
- 急性非ST段抬高心肌梗死 /
- 血管成形术 /
- 经皮冠状动脉 /
- 预后
Abstract: Objective: To assess the predictive values of ACUITY-PCI scores in patients with non-ST-segment elevation acute myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI).Method: Patients with NSTEMI undergoing PCI in Anzhen Hospital from January 2009 to December 2012 were enrolled, calculated the ACUITY PCI score and followed up for 2 years with all-cause mortality, nonfatal myocardial infarction and revasculation as the endpoints.Result: During the follow-up, major adverse cardiac events (MACE) occurred in 47 patients, among which 4 patients had a low score, accounting for 8.5%, 22 patients had an intermediate score, accounting for 46.8%, and 21 patients had a high score, accounting for 44.7%.The difference between three groups was statistically significant (P＜0.001).The difference between high score group and intermediate score group was statistically significant[HR=3.87, 95%CI (1.43, 10.49), P=0.008].Area under receiving operator curve (AUROC) was 0.727[95%CI (0.656, 0.797), P＜0.001].Conclusion: ACUITY-PCI score is an ideal tool for prognosis in NSTEMI patients with PCI. -
-
[1] ALTMAN D G, ROYSTON P.What do we mean by validating aprognostic model?[J].Stat Med, 2000, 19:453-473.
[2] EAGLE K A, LIM M J, DABBOUS O H, et al.A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry[J].JAMA, 2004, 291:2727-2733.
[3] LANSKY A J, GOTO K, CRISTEA E, et al.Clinical and angiographic predictors of short-and longterm ischemic events in acute coronary syndromes:results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY-PCI) trial[J].Circ Cardiovasc Interv, 2010, 3:308-316.
[4] THYGESEN K, AIPERT JS, WHITE HD, et al.Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myoeardial Infarction.Universal definition of myoeardial infarction[J].J Am Coll Cardiol, 2007, 50:2173-2195.
[5] PALMERINI T, GENEREUX P, CAIXETA A, et al.A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention:the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score[J].JACC Cardiovasc Interv, 2012, 5:1108-1116.
[6] CANNON C P, WEINTRAUB W S, DEMOPOULOS L A, et al.Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban[J].N Engl J Med, 2001, 344:1879-1887.
[7] PALMERINI T, GENEREUX P, CAIXETA A, et al.Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention:analysis from the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy) trial[J].J Am Coll Cardiol, 2011, 57:2389-2397.
[8] TRICOCI P, HUANG Z, HELD C, et al.Thrombin-receptor antagonist vorapaxar in acute coronary syndromes[J].N Engl J Med, 2012, 366:20-33.
-
计量
- 文章访问数: 206
- PDF下载数: 66
- 施引文献: 0
下载: